Phase IIa Study Evaluating AZD7798 in Crohn's Disease | MicrobiomeTrials

← Back to trials

NCT06450197

Phase IIa Study Evaluating AZD7798 in Crohn's Disease

RecruitingPHASE2INTERVENTIONAL

Trial Details

Start: 2024-08-28Est. Completion: 2026-04-30

Enrollment target: 120 participants

Locations

Research Site, Phoenix, Arizona, United States
Research Site, Escondido, California, United States
Research Site, La Jolla, California, United States
Research Site, Orlando, Florida, United States
Research Site, Idaho Falls, Idaho, United States
Research Site, Kansas City, Kansas, United States
Research Site, Clinton Township, Michigan, United States
Research Site, St Louis, Missouri, United States
Research Site, Asheville, North Carolina, United States
Research Site, Charlotte, North Carolina, United States
Research Site, Uniontown, Pennsylvania, United States
Research Site, Garland, Texas, United States
Research Site, San Antonio, Texas, United States
Research Site, CABA, Argentina
Research Site, CABA, Argentina
Research Site, Ciudad Autonoma de Bs As, Argentina
Research Site, Ciudad de Buenos Aires, Argentina
Research Site, San Miguel de Tucumán, Argentina

Other microbiome trials you might be interested in

A Clinical Trial of Taibowei® Adalimumab Injection in the Treatment of Chinese Pediatric Patients With Moderately to Severely Active Crohn's DiseasePhase 4Recruiting

Children Aged 6 Years and Above With Moderate - to - Severe Active Crohn's Disease

This study is a real - world clinical research of adalimumab. The project plans to enroll 30 subjects, aiming to evaluat…

Guangzhou, ChinaEst. completion Mar 2029

Intertriginous/Periorificial Dermatoses in Patients With IBD on Anti-TNFα: Relative Abundance of Staphylococcus Aureus Within the Lesion Microbiota and Clinical Correlation (micSPIDER).Recruiting

Inflammatory Bowel DiseasesCrohn's DiseaseSkin DiseasesDermatitis

The main objective of this study is to evaluate the change in the relative abundance of S. aureus within the lesion-site…

Millau, FranceEst. completion Sep 2028

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.